|
Cleanascite™ Cited in Stroke Research Study Biotech Support Group (BSG) reports on its proprietary lipid removal reagent, Cleanascite™, as a essential method to assess the functional effects of circulating lipids after stroke. Cleanascite™ Cited in Stroke Research Study
MONMOUTH JUNCTION, NJ, February 6, 2026 — Biotech Support Group (BSG) reports on its proprietary lipid removal reagent, Cleanascite™, as a essential method to assess the functional effects of circulating lipids after stroke.
The abstract reports that importantly, de-lipidation of stroke plasma restored function across all measures: preventing neutrophil lipid accumulation, impaired bacterial clearance (p<0.05), and diminished antigen processing (p<0.01). Similar findings were seen in vivo after repeated infusions of de-lipidated stroke plasma, supporting the idea that lipids are key drivers of post-stroke immune suppression.
“Cleanascite™ is now commonly used in many applications to remove lipids in order to determine the degree to which lipids are the biological effectors of a particular outcome. This is one of many references that demonstrate its advantaged workflow as a simple to use sample prep product to clear lipid factors from biofluids, without introducing any confounding artifacts.” stated Dr. Swapan Roy, President and Founder of Biotech Support Group.
For
additional product details, visit: About
Biotech Support Group LLC
For
Business Development Inquiries: Keywords: Cleanascite™, plasma lipid depletion, stroke, immune suppression |
- About
- Products
- Albumin Removal Products
- Hemoglobin Removal Kits
- Lipid Removal & Clarification
- Urine Protein & Low Abundance Enrichment
- Class Specific Enrichment
- Sample Prep Mass Spectrometry
- Functional & Chemical Proteomics
- Genomic Sample Prep
- Accessories
- Technical Resources
- References
- Publications & Reports
- FAQs
- Case Studies
- Cleanascite™ Unlocks Insights into Lipid-Driven Tumor Immunosuppression
- NRicher™ Bead Platform Provides Unique Sub-Proteome Biases And Fit For Purpose Opportunities for Targeted LC-MS Quantification
- BSG Products To Assist in Analyzing Macrophage Polarization
- Ectodomain Shedding and Enrichment of the Soluble Membrane Proteome
- Investigate out of the Venn Diagram box
- Methods to selectively deplete or purify Hemoglobin from Dried Blood Spots (DBS)
- The Utility of HemoVoid™ is Demonstrated in 3 Proteomic Investigations Identifying Potential Disease Specific Biomarkers
- The 4 common features of our sample prep products, known as the BSG Advantage, are highlighted in a selection of journal references.
- AlbuVoid™ Workflows Advance Cell Secretome Proteomics
- Lipid Removal for Phenotypic Cell Response in Cancer Research
- The Influence of Sample Prep Bias on LC-MS Targeted Peptide Quantification in Serum Proteomics
- Re-imagining proteomics for developing precision medicine biomarkers of the innate immune response in SARS-CoV-2
- Patent Application Describes New Proteomic Methods to Monitor Protease Inhibitor Function During Covid-19 Infections
- Efficient Hemoglobin Removal Advances Red Cell Proteomics Offering Many New Insights Into Inflammation and Infectious Disease
- The Potential for New Blood Biomarkers in the Management of COVID-19 Disease
- Establishing the Utility of HemoVoid™ and HemogloBind™ as Enrichment Tools for Proteomic Analysis of Red Cells and Whole Blood in Parkinson’s Disease
- Species Diversity Supported By BSG Products
- Poster Report Describes Loss of Functional Serpin Activity In Cancer Patient Blood
- AlbuVoid™️ PLUS & AlbuSorb™️ PLUS Evaluating Different Windows of Observation Solves The Many Challenges of Serum Proteomics
- Tackling the Challenges of Serum Proteomics
- Lipid Removal Sample Prep for Cell Response Applications
- Sample Prep for Proteomic Analysis of Saliva
- Biotech Support Group Featured in Book, "Functional Proteomics – Methods and Protocols"
- Sample Prep Liquid Biopsy Products Suitable for Proteomic Profiling of a Variety of Body Fluid Sample Types
- Albumin and High Abundance Depletion
- Using HemogloBind™ as a Hemoglobin Binding Reagent
- Diverse technologies available for researchers to selectively bind or enrich exosomes and extracellular vesicles.
- Stroma Liquid Biopsy™ Biomarkers Profile Pan-Cancer Dysregulation of the Serum Proteome
- Diverse Depletion and Enrichment Technologies Enhance Simplicity and Efficiency of Obtaining Quality Proteomic Information
- Use On-Bead Digestion to Improve Time Required for Serum Digestion
- Using AlbuVoid™ as a Serum Protein Enrichment Kit in Functional Proteomics
- Using Cleanascite™ as a Lipid Absorption and Clarification Reagent
- Using HemoVoid to Remove Hemoglobin Before Analysis
- Blog
- Contact
- Liquid Biopsy
In Abstracts from the American Stroke Association's 2026
International Stroke Conference, researchers from UT Health,
highlight the use of Cleanascite™
to compare stroke plasma, in ex vivo models of immune suppression.
The abstract is entitled “